Paediatric Drug Development 2011

Key Speakers Samuel Maldonado, Vice-President and Head of Paediatric Drug Development 2011, Johnson & Johnson David McIntosh, Global Scientific Affairs Senior Expert, Novartis Hans-Leonhard Ohrem, Technical Manager, Merck Deborah Bickmann, Boehringer Ingelheim Jacek Bedkowski, Senior Regulatory Affairs Associate, Baxter Sarah Branch, Special Populations Group Manager, MHRA Klaus Rose, Principal Consultant, Granzer Regulatory Consulting & Services (Former Head of Paediatrics, Roche) Philippa Smit-Marshall, Vice President, Medical Affairs, Pharmanet Consultancy Ian Friedland, Study Director, Cubist Pharmaceuticals Timo Vesikari, Professor of Virology and Consultant Paediatrician, University of Tampere Daniel Bar-Shalom, Associate Professor, University of Copenhagen Steffen Gay, Department of Rheumatology, University Hospital Z rich

Visitors profile
Senior VPs, Chief Scientific Officers, Directors, Managers, Professors, Scientists, and Principal Investigators in: Paediatric Medicine Research & Development Clinical Trials Therapeutics Drug Delivery Drug Discovery Formulation Devel